Xperix엑스페릭스

Xperix's revenue has grown strongly since 2023, but it still runs operating losses and is raising capital and issuing convertible bonds.

Xperix, a KOSDAQ-listed maker of biometric devices such as fingerprint enrollment units and passport readers, reported trailing revenue of ₩25.0B through H1 2026 with an operating loss of ₩1.3B and a small net profit of ₩0.3B. The filings show a heavy financing load: borrowings of ₩32.6B against cash of ₩12.2B, and negative free cash flow of ₩3.6B. Shares closed at ₩2,390 on 2026-10-26, down 36.5% over one year and well below the 52-week high of ₩4,735.

What stands out

• Revenue rose 45.7% in 2025 to ₩21.5B, but the company posted a net loss of ₩19.5B that year.
• Trailing operating margin is -5.3%, and the reported net profit depends on items other than core operations.
• Trailing P/E is 253.7 and P/B is 0.9; the data gives no fair value estimate.
• Recent filings include multiple convertible bond issues, conversion price adjustments, a rights offering and a small-scale public offering, pointing to ongoing fundraising.
• Headlines report that a sale of a subsidiary stake has stalled and that a major shareholder has exited, and foreign ownership is 2.4%.

What to watch

• Whether the rights offering and public offering are completed and how they affect the share count and dilution.
• Progress on the stalled subsidiary stake sale and any further conversion price adjustments on the convertible bonds.
• Next periodic results, to see whether operating income turns positive and free cash flow improves against ₩32.6B in borrowings.